Detalhe da pesquisa
1.
Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae.
BMC Infect Dis
; 21(1): 1079, 2021 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666695
2.
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
BMC Infect Dis
; 17(1): 203, 2017 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283020
3.
QuantiFERON-TB and tuberculin skin test in patients with active tuberculosis: the experience of a single medium-sized Italian University Hospital.
Infez Med
; 29(2): 229-235, 2021 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34061788
4.
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project.
BioDrugs
; 35(6): 749-764, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637126
5.
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
N Engl J Med
; 353(10): 977-87, 2005 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16148283
6.
Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis.
Lancet Infect Dis
; 2(4): 231-42, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11937423
7.
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia.
J Clin Oncol
; 32(14): 1463-71, 2014 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24733807
8.
Reply to J.H. Joshi.
J Clin Oncol
; 32(34): 3899-900, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25225423
9.
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Cancer
; 107(8): 1743-51, 2006 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16977651
10.
Prophylaxis and treatment of bacterial infections: do we need new strategies?
Rev Clin Exp Hematol
; 9(2): E4, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16864118